Benitec Biopharma
BNTC
BNTC
57 hedge funds and large institutions have $265M invested in Benitec Biopharma in 2025 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 13 increasing their positions, 12 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
57
Holders Change
+20
Holders Change %
+54.05%
% of All Funds
0.76%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
25
Increased
13
Reduced
12
Closed
5
Calls
–
Puts
$7K
Net Calls
-$7K
Net Calls Change
-$7K
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.51M |
| 2 |
BlackRock
New York
|
+$6.25M |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$2.12M |
| 4 |
State Street
Boston,
Massachusetts
|
+$1.64M |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$941K |
Top Sellers
| 1 |
IAM
Infinitum Asset Management
Fort Lauderdale,
Florida
|
-$7.31M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$2.44M |
| 3 |
Franklin Resources
San Mateo,
California
|
-$1.86M |
| 4 |
Millennium Management
New York
|
-$417K |
| 5 |
HF
HRT Financial
New York
|
-$337K |
